Allick, Gideon, Saskia N. van der Crabben, Mariette T. Ackermans, Erik Endert, and Hans P. Sauerwein. Measurement of gluconeogenesis by deuterated water: the effect of equilibration time and fasting period. Am J Physiol Endocrinol Metab 290: E1212-E1217, 2006. First published January 10, 2006 doi:10.1152/ajpendo.00279.2005.-Fasting gluconeogenesis (GNG) is often quantified using the 2 H2O technique, which is based on plasma 2 H2O enrichment and ensuing enrichment of plasma glucose at the C5 and C2 positions. Fractional (fr)GNG can be calculated using the ratio of C5 to C2 enrichment or the ratio of C5 to plasma 2 H2O enrichment. For the latter, equilibration of 2 H2O and C2 is required. The optimal equilibration period of 2 H2O and C2 remains to be elucidated. In six healthy male subjects fasted for 18 h, we studied the effects of 3-, 5-, and 15-h 2 H2O incubation periods on 1) the equilibration of plasma 2 H2O and C2 glucose enrichment, 2) the measurement of frGNG, and 3) C5 labeling of hepatic glycogen after 1 mg of glucagon administration. After 3-h 2 H2O incubation, plasma 2 H2O and C2 were not equilibrated, frGNG C5/ 2 H2O and C5/C2 were also different as was gluconeogenesis calculated with C5/ 2 H2O and C5/C2. After 5-and 15-h 2 H2O incubation, plasma 2 H2O and C2 were equilibrated, and frGNG C5/ 2 H2O and C5/C2 were similar, as was GNG calculated with C5/ 2 H2O and C5/C2. After glucagon administration, no difference of C5 enrichment was found between 3, 5, and 15 h of 2 H2O incubation. In conclusion, for reliable measurement of GNG in healthy subjects with C5/ 2 H2O incubation periods longer than 3 h are required. After 5-and 15-h 2 H2O incubation, GNG can be reliably measured with C5/ 2 H2O. Gluconeogenetic labeling of glycogen did not affect the results after 3, 5, or 15 h of 2 H2O incubation.
. Glucose produced by gluconeogenesis after ingestion of 2 H 2 O will be labeled with deuterium at the C5 position. Glucose molecules produced by gluconeogenesis and glycogenolysis will be labeled with deuterium at the C2 position. The ratio of C5 and C2 enrichment of glucose constitutes fractional gluconeogenesis. Alternatively, fractional gluconeogenesis can be calculated by the ratio of C5 enrichment of glucose and plasma 2 H 2 O enrichment. A requirement for the latter method is the complete equilibration of plasma 2 H 2 O enrichment with C2 enrichment of glucose (9) (6, 11, 12) . For reliable measurement of fractional gluconeogenesis using the fraction of C5 and plasma 2 H 2 O enrichment, a long equilibration period seems to be required.
Besides the possible advantage of a long equilibration period, a disadvantage could be invoked. In the fasted state, glycogen cycling is thought to persist (7, 10) . This could cause labeling of hepatic glycogen by incorporation of gluconeogenetically labeled glucose. Breakdown of this glycogen during measurement of fractional gluconeogenesis could result in an overestimation of gluconeogenesis at the expense of glycogenolysis. On the other hand, during short equilibration periods, glycogen cycling could underestimate gluconeogenesis if gluconeogenetically labeled glucose is incorporated into glycogen while unlabeled glucose is released from glycogen. Glycogen labeling during equilibration can be investigated by measuring C5 enrichment of glucose immediately after glucagon administration. As glucagon is a powerful stimulator of glycogenolysis, differences of C5 enrichment between short and long equilibration periods would indicate gluconeogenetic labeling of glycogen. In many of the 2 H 2 O studies performed by our and other groups, long equilibration periods (ϳ15 h) were used to guarantee equilibration of plasma 2 H 2 O and C2 glucose enrichment (2, 3).
2 H 2 O ingestion a few hours before the study is preferable: possible labeling of glycogen is minimized and overnight admission of subjects is prevented. However, the shortest 2 H 2 O equilibration period for reliable measurement of gluconeogenesis remains to be investigated.
To find the optimal 2 H 2 O equilibration period, we studied the effects of 3-, 5-, and 15-h 2 H 2 O incubation periods on 1) the equilibration of plasma 2 H 2 O and C2 glucose enrichment, 2) the measurement of fractional gluconeogenesis using the ratio of C5 to 2 H 2 O enrichment (C5/ 2 H 2 O) and the ratio of C5 to C2 enrichment (C5/C2), and 3) C5 glucose enrichment after glucagon administration.
METHODS
Subjects. Six healthy males (age 22-31 yr; body mass index 20 -25 kg/m 2 ) were studied on three separate occasions after an overnight fast. All subjects were in good health, had no family history of diabetes, and did not use any medication. Participating subjects gave written informed consent. This study was approved by the medical ethics committee of the Academic Medical Center.
Protocol. Fasting commenced at 7:00 PM (t ϭ 0:00) on the evening before the studies and lasted until 1:00 PM the next day (t ϭ 18:00). Subjects were studied in the supine position. Three studies with different 2 H2O incubation periods were performed in each subject (Fig. 1) . In each study, blood samples for measurement of gluconeogenesis were drawn at exactly the same time to prevent the influence of diurnal variation of gluconeogenesis on the results. Depending on the study protocol, subjects were studied from t ϭ 14:00 until t ϭ 17:00 in the short incubation study, from t ϭ 12:00 until t ϭ 17:00 in the medium incubation study, and from t ϭ 2:00 until t ϭ 17:00 in the long incubation study. The sequence of studies was determined by random assignment with an interval of Ն8 wk between studies to preclude underestimation of fractional gluconeogenesis due to C5 glucose enrichment derived from previous experiments. Before ingestion of 2 H2O, a catheter was inserted into an antecubital vein for blood sampling. The hand was kept in a heated hand box at 60°C to allow arterialization of venous blood. Short 2 H2O incubation study, 3 h. At 8:45 AM, a catheter was inserted into a contralateral antecubital vein for infusion of [6,6-2 H2]glucose. After drawing of blood samples for determination of background enrichments of plasma glucose, 2 H2O (Ͼ99.8% enriched; Cambridge Isotopes, Andover, MA) was ingested every half-hour from 9:00 to 11:00 AM (from t ϭ 14:00 to t ϭ 16:00), up to a total dose of 5 g/kg body water to achieve a plasma 2 H2O enrichment of ϳ0.5%. Body water was estimated to be 60% of total body weight. Water consumed during the remainder of the study was enriched with 0.5% 2 H2O to maintain isotopic steady state. At 9:00 AM, after taking of a blood sample for background enrichment of plasma glucose, a primed continuous infusion of [6,6- H2O incubation study, 5 h. After drawing of blood samples for determination of background enrichments of plasma glucose, 2 H2O (5 g/kg body water) was ingested every half-hour from 7:00 to 9:00 AM (from t ϭ 12:00 to t ϭ 14:00). Isotope administration and blood sampling protocol were identical to those in the short 2 H2O incubation study. Long 2 H2O incubation study, 15 h. On the night before the study, after drawing of blood samples for determination of background enrichments of plasma glucose, 2 H2O (5 g/kg body water) was ingested every half-hour from 9:00 to 11:00 PM (from t ϭ 2:00 to t ϭ 4:00). Isotope administration and blood sampling protocol were identical to those in the short and medium 2 H2O incubation studies. Gas chromatography-mass spectrometry. Enrichments of plasma [6,6- 2 H2]glucose, plasma 2 H2O, and deuterium at the C5 and C2 position of glucose were determined as described previously (1) . Briefly, plasma samples for glucose enrichments of [6,6- 2 H2]glucose and glucose concentration were measured as the aldonitril pentaacetate derivative of glucose in deproteinized plasma, using xylose as an internal standard. Glucose was monitored at mass-to-charge ratios ]glucose was determined by dividing the peak area of m/z 189 by the peak area of m/z 187 and correcting for natural enrichments. To measure deuterium enrichment at the C5 and C2 positions, glucose was converted to hexamethylenetetramine (HMT) as described by Landau et al. (9) . HMT was injected into a gas chromatograph-mass spectrometer. Separation was achieved on an AT-Amine column (30 m ϫ 0.25 mm, d f 0.25 m). All isotopic enrichments were measured on a gas chromatograph-mass spectrometer (model 6890 gas chromatograph coupled to a model 5973 mass selective detector, equipped with electron impact ionization mode; HewlettPackard, Palo Alto, CA).
Analytic procedures. Plasma insulin concentration was determined by a chemiluminiscent immunometric assay (Immulite; Diagnostic Products, Los Angeles, CA), intra-assay coefficient of variation (CV) 3-6%, interassay CV 3-5%, detection limit 14 pmol/l. Glucagon was determined by RIA (Linco Research, St. Charles, MO), intra-assay CV 3-5%, interassay CV 9 -13%, detection limit 15 ng/l.
Calculation and statistics. The fractional rate of gluconeogenesis was calculated using two methods: by dividing deuterium enrichment at the C5 position of plasma glucose by plasma 2 H2O enrichment and by dividing deuterium enrichment at the C5 position of plasma glucose by deuterium enrichment at the C2 position of plasma glucose. Glucose production before glucagon administration (t ϭ 16:30, 16:45, and 17:00) was calculated by dividing the infusion rate of [6,6- 2 H2]glucose by the resulting M ϩ 2 tracerto-tracee ratio of plasma aldonitril pentaacetate glucose, after ascertaining that the M ϩ 2 tracer/tracee ratios were in steady state. Gluconeogenesis was calculated by multiplying fractional gluconeogenesis by glucose production and is expressed as micromoles per kilogram per minute.
Differences between groups and studies were analyzed using the Wilcoxon signed ranks test of SPSS (v.11.5.2; SPSS, Chicago, IL). A P value of Ͻ0.05 was considered statistically significant. Data are presented as means Ϯ SD. Plasma 2 H2O enrichment and C2 enrichment of glucose were considered equilibrated when no statistically significant difference was found between plasma 2 H2O and glucose C2 enrichment.
RESULTS

Plasma
2 H 2 O enrichment and C2 enrichment of glucose. In the short incubation study, plasma 2 H 2 O enrichment and C2 enrichment of glucose were not equilibrated at t ϭ 16:30 and t ϭ 16:45, whereas they were similar at t ϭ 17:00 (2.5-to 3-h incubation). In the medium and long incubation studies, plasma 2 H 2 O enrichment and C2 enrichment of glucose were equilibrated from t ϭ 16:30 to t ϭ 17:00 (4.5-to 5-h incubation in the medium study, 14.5-to 15-h incubation in the long incubation study; Table 1 and Fig. 2) .
The minimum time required to achieve equilibration of 2 H 2 O enrichment and C2 enrichment was 3 h in the short and medium incubation studies and 6 h in the long incubation study.
Fractional gluconeogenesis and gluconeogenesis measured with
2 H 2 O and C2 enrichment. Fractional gluconeogenesis can be calculated using two methods: by the ratio of C5 and 2 H 2 O enrichment (C5/ 2 H 2 O) and by the ratio of C5 and C2 enrichment (C5/C2). In the short incubation study, C5/ 2 H 2 O and C5/C2 were different at t ϭ 16:30 and t ϭ 16:45, whereas they were similar at t ϭ 17:00. In the medium and long incubation studies, C5/ 2 H 2 O and C5/C2 were similar from t ϭ 16:30 to t ϭ 17:00 (Table 2) .
Gluconeogenesis was calculated by multiplying glucose production by C5/ 2 H 2 O and multiplying glucose production by C5/C2. In the short incubation study, gluconeogenesis calculated with C5/ 2 H 2 O was consistently lower than gluconeogenesis calculated with C5/C2 from t ϭ 16:30 to t ϭ 17:00. In the medium and long incubation studies, gluconeogenesis calcu- (Tables 3 and 4) .
Glucagon administration: C5 and C2 enrichment of glucose and fractional gluconeogenesis. Before glucagon administration at t ϭ 17:00, C5 enrichment was similar in the short, medium, and long incubation studies. After glucagon administration, C5 enrichment was not different between any of the studies from t ϭ 17:15 to t ϭ 18:00, nor was the area under the curve of C5 different between studies (short vs. medium P ϭ 0.69; short vs. long P ϭ 0.68; medium vs. long P ϭ 0.79). Although no differences in C5 enrichment between the incubation studies were observed, administration of glucagon did cause changes in C5 enrichment compared with the baseline C5 enrichment at t ϭ 17:00 in individual incubation studies. In the short incubation study, glucagon tended to decrease C5 enrichment at t ϭ 17:15 and t ϭ 17:30 (P ϭ 0.07 and P ϭ 0.07, respectively). In the medium incubation study, no changes in C5 enrichment were observed. In the long incubation study, C5 enrichment was decreased at t ϭ 17:15, 17:30, and at 17:45 (P ϭ 0.04, 0.03, and 0.04, respectively) and tended to be decreased at t ϭ 18:00 (P ϭ 0.08; Table 6 ).
C2 enrichment was similar in the short, medium, and long incubation studies before and after glucagon administration and was not influenced by glucagon in any of the individual studies compared with baseline values at t ϭ 17:00.
Fractional gluconeogenesis (C5/C2) was not different between the short, medium, and long incubation studies before and after glucagon administration. Some of the changes seen in C5 enrichment after the administration of glucagon were reflected in fractional gluconeogenesis: in the short incubation study, fractional gluconeogenesis tended to be decreased at t ϭ 17:30 (P ϭ 0.08) compared with baseline at t ϭ 17:00. In the medium incubation study, no changes were observed, whereas in the long incubation studies fractional gluconeogenesis was decreased or tended to be decreased from t ϭ 17:15 onward (P ϭ 0.04, 0.07, 0.07, and 0.04 at t ϭ 17:15, 17:30, 17:45, and 18:00, respectively; Table 6 ).
DISCUSSION
This study shows that 3 h of 2 H 2 O incubation in the short study was insufficient to completely equilibrate plasma 2 H 2 O and C2 glucose enrichment. Fractional gluconeogenesis calculated using the C5/ 2 H 2 O ratio tended to be lower than the C5/C2 ratio due to incomplete equilibration in the short study. This difference is ultimately reflected in calculated rates of gluconeogenesis. After 5 and 15 h of 2 H 2 O incubation, equilibration of plasma 2 H 2 O enrichment and C2 glucose enrichment was achieved, and C5/ 2 H 2 O and C5/C2 and calculated rates of gluconeogenesis were similar. Gluconeogenetic labeling of hepatic glycogen did not appear to have influenced the measurement of gluconeogenesis in any of the studies, as no differences in C5 glucose enrichment between the studies were found after administration of glucagon.
The prerequisite for calculating fractional gluconeogenesis with C5/ 2 H 2 O instead of C5/C2 is the complete equilibration of plasma 2 H 2 O enrichment with C2 glucose enrichment. Equilibration of plasma 2 H 2 O and C2 enrichment indicates equilibration of 2 H 2 O with the intrahepatic glucose 6-phosphate pool. The present study shows that 3 h of 2 H 2 O incubation in the short incubation study is barely enough to achieve complete equilibration: the plasma 2 H 2 O enrichment was lower than the C2 glucose enrichment at t ϭ 16:30 and t ϭ 16:45 and was scarcely equilibrated at t ϭ 17:00. Because the last 2 H 2 O dose was ingested half an hour before the first sample for isotopic enrichment was drawn at t ϭ 16:30, incomplete equilibration was most likely due to insufficient time for incorporation of deuterium label into endogenously produced glucose. Results from the medium and long incubation studies indicate that 5 and 15 h of 2 H 2 O incubation are sufficient to reach equilibration, enabling reliable calculation of gluconeogenesis with the C5/ 2 H 2 O ratio. Figure 2 depicts the equilibration of plasma Values are expressed as means Ϯ SD. TTR, tracer-to-tracee ratio; GP, glucose production.
2 H 2 O and C2 glucose enrichment over time and shows that equilibration in the short and medium incubation studies was only just achieved after 3 h of incubation. However, in the long incubation study, 6 h of incubation was needed for equilibration. Although this remarkable difference remains unexplained, it could be due to the relatively short time of fasting during 2 H 2 O incubation and indicates that fasting period also plays a role in the equilibration of plasma 2 H 2 O and C2 glucose enrichment. In the long incubation study, 2 H 2 O was ingested 2 h after the last meal, when the subjects were still in the absorptive state. The absorptive state is characterized by influx of exogenous glucose, high insulin levels, and suppressed glucose production and generally lasts for 4 h until the postabsorptive state is reached, which is characterized by decreased insulin levels and increased glucose production. Although glucose production was not investigated until 16.5 h of fasting, suppressed glucose production could have disturbed the equilibration of plasma 2 Figure 2 suggests a minimum incubation period of 3 h in the medium incubation study and 6 h in the long study. Although the shortest incubation period cannot be pinpointed in the present study, it can be concluded that a 2 H 2 O incubation period greater than 3 h is required when 2 H 2 O is ingested in the postabsorptive state.
Gluconeogenetic labeling of hepatic glycogen cannot be excluded, as glucagon administration had different effects on C5 glucose enrichment in each of the incubation studies: a tendency to decrease in the short incubation study, no effect in the medium incubation study, and a decrease in the long incubation study. Because glucagon is a powerful stimulator of glycogenolysis, the observed decrease in C5 enrichment is likely to have been caused by increased glycogenolysis at the cost of gluconeogenesis. It remains unclear why glucagon administration did not affect C5 enrichment in the medium incubation study. Although some gluconeogenetic labeling of hepatic glycogen during 2 H 2 O incubation cannot be excluded, its effect on the measurement of gluconeogenesis is limited, as no differences of C5 enrichment before and after glucagon administration were found between the short, medium, and long incubation studies.
In Values are expressed as means Ϯ SD.
